Erratum: Inclusion of new 5-fluorouracil amphiphilic derivatives in liposome formulation for cancer treatment (Med. Chem. Commun. (2015) 6 (1639-1642))

M. Petaccia; M. Condello; L. Giansanti; A. La Bella; F. Leonelli; S. Meschini; D. Gradella Villalva; E. Pellegrini; F. Ceccacci; L. Galantini; G. Mancini

ArticleOPEN ACCESS

Erratum: Inclusion of new 5-fluorouracil amphiphilic derivatives in liposome formulation for cancer treatment (Med. Chem. Commun. (2015) 6 (1639-1642))

Petaccia M
Condello M
Giansanti L
et al.

MedChemComm

DOI: 10.1039/c5md90061a

4Citations

8Readers

Abstract

Correction for 'Inclusion of new 5-fluorouracil amphiphilic derivatives in liposome formulation for cancer treatment' by M. Petaccia et al., Med. Chem. Commun., 2015, 6, 1639-1642.

Cite

CITATION STYLE

APA

Petaccia, M., Condello, M., Giansanti, L., La Bella, A., Leonelli, F., Meschini, S., … Mancini, G. (2016, February 1). Erratum: Inclusion of new 5-fluorouracil amphiphilic derivatives in liposome formulation for cancer treatment (Med. Chem. Commun. (2015) 6 (1639-1642)). MedChemComm. Royal Society of Chemistry. https://doi.org/10.1039/c5md90061a

Erratum: Inclusion of new 5-fluorouracil amphiphilic derivatives in liposome formulation for cancer treatment (Med. Chem. Commun. (2015) 6 (1639-1642))

Abstract

Cite

Register to see more suggestions